These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 14511358)

  • 1. Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: relation with the disease stage and effect of bile acid treatment.
    Grattagliano I; Giudetti AM; Grattagliano V; Palmieri VO; Gnoni GV; Lapadula G; Palasciano G; Vendemiale G
    Eur J Clin Invest; 2003 Oct; 33(10):868-74. PubMed ID: 14511358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patients.
    Grattagliano I; Palmieri VO; Portincasa P; Minerva F; Palasciano G
    Clin Biochem; 2011 Dec; 44(17-18):1400-4. PubMed ID: 21963381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Poupon RE; Ouguerram K; Chrétien Y; Verneau C; Eschwège E; Magot T; Poupon R
    Hepatology; 1993 Apr; 17(4):577-82. PubMed ID: 8477962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis.
    Balan V; Dickson ER; Jorgensen RA; Lindor KD
    Mayo Clin Proc; 1994 Oct; 69(10):923-9. PubMed ID: 7934188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of ursodeoxycholic acid on early-stage primary biliary cirrhosis.
    Kao JH; Lai MY; Lin JT; Yang PM; Sheu JC; Chen DS; Sung JL; Wang TH
    J Formos Med Assoc; 1991 Oct; 90(10):970-4. PubMed ID: 1685179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in lipid composition of erythrocyte membranes with administration of S-adenosyl-L-methionine in chronic liver disease.
    Kakimoto H; Kawata S; Imai Y; Inada M; Matsuzawa Y; Tarui S
    Gastroenterol Jpn; 1992 Aug; 27(4):508-13. PubMed ID: 1526432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.
    Ricci P; Hofmann AF; Hagey LR; Jorgensen RA; Rolland Dickson E; Lindor KD
    Dig Dis Sci; 1998 Jun; 43(6):1292-5. PubMed ID: 9635620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ursodeoxycholic acid administration on biliary lipid secretion in primary biliary cirrhosis.
    Roda E; Mazzella G; Bazzoli F; Villanova N; Minutello A; Simoni P; Ronchi M; Poggi C; Festi D; Aldini R
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):52S-58S. PubMed ID: 2598768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholate has no beneficial effect on liver function or histology in biliary cirrhosis in the rat.
    Zimmermann H; Reichen J
    J Hepatol; 1992 Nov; 16(3):355-9. PubMed ID: 1487614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vitamin D level is associated with disease severity and response to ursodeoxycholic acid in primary biliary cirrhosis.
    Guo GY; Shi YQ; Wang L; Ren X; Han ZY; Guo CC; Cui LN; Wang JB; Zhu J; Wang N; Zhang J; Cai Y; Han Y; Zhou XM; Fan DM
    Aliment Pharmacol Ther; 2015 Jul; 42(2):221-30. PubMed ID: 25982180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
    Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
    Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
    Mazzella G; Parini P; Bazzoli F; Villanova N; Festi D; Aldini R; Roda A; Cipolla A; Polimeni C; Tonelli D
    Dig Dis Sci; 1993 May; 38(5):896-902. PubMed ID: 8482188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling.
    Rudi J; Waldherr R; Raedsch R; Kommerell B
    J Hepatol; 1995 Jan; 22(1):43-9. PubMed ID: 7751586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholic acid and ursodeoxycholic acid therapy in primary biliary cirrhosis. Changes in bile acid patterns and their correlation with liver function.
    Güldütuna S; Leuschner M; Wunderlich N; Nickel A; Bhatti S; Hübner K; Leuschner U
    Eur J Clin Pharmacol; 1993; 45(3):221-5. PubMed ID: 8276045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial.
    Leuschner U; Fischer H; Kurtz W; Güldütuna S; Hübner K; Hellstern A; Gatzen M; Leuschner M
    Gastroenterology; 1989 Nov; 97(5):1268-74. PubMed ID: 2551765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid.
    Stojakovic T; Putz-Bankuti C; Fauler G; Scharnagl H; Wagner M; Stadlbauer V; Gurakuqi G; Stauber RE; März W; Trauner M
    Hepatology; 2007 Sep; 46(3):776-84. PubMed ID: 17668874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.